Zhejiang Anglikang Pharmaceutical Co. Ltd. (002940) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Anglikang Pharmaceutical Co. Ltd.

Why is Zhejiang Anglikang Pharmaceutical Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.31% and Operating profit at -6.58% over the last 5 years

With a growth in Net Sales of 20.67%, the company declared Very Positive results in Sep 25

The company has declared positive results in Jan 70 after 7 consecutive negative quarters
PRE-TAX PROFIT(Q) At CNY 23.48 MM has Grown at 179.11%
NET PROFIT(Q) At CNY 11.76 MM has Grown at 164.77%
RAW MATERIAL COST(Y) Fallen by -32.78% (YoY)

With ROE of 7.02%, it has a expensive valuation with a 4.85 Price to Book Value

Over the past year, while the stock has generated a return of 126.62%, its profits have fallen by -38.6%
At the current price, the company has a high dividend yield of 0.3

Market Beating Performance

The stock has generated a return of 126.62% in the last 1 year, much higher than market (China Shanghai Composite) returns of 16.01%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Anglikang Pharmaceutical Co. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Anglikang Pharmaceutical Co. Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Anglikang Pharmaceutical Co. Ltd.

126.62%

1.41

69.23%

China Shanghai Composite

16.01%

1.07

14.99%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.31%

EBIT Growth (5y)

-6.58%

EBIT to Interest (avg)

71.12

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.66

Tax Ratio

1.73%

Dividend Payout Ratio

30.64%

Pledged Shares

Institutional Holding

ROCE (avg)

13.84%

ROE (avg)

10.46%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.85

EV to EBIT

130.95

EV to EBITDA

54.14

EV to Capital Employed

5.07

EV to Sales

5.39

PEG Ratio

Dividend Yield

0.33%

ROCE (Latest)

3.87%

ROE (Latest)

7.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 23.48 MM has Grown at 179.11%

NET PROFIT(Q)

At CNY 11.76 MM has Grown at 164.77%

RAW MATERIAL COST(Y)

Fallen by -32.78% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 8.09 times

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 194.68 MM

DEBT-EQUITY RATIO (HY)

Highest at 1.27 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.92 times

Here's what is working for Zhejiang Anglikang Pharmaceutical Co. Ltd.

Pre-Tax Profit

At CNY 23.48 MM has Grown at 179.11%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 11.76 MM has Grown at 164.77%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Debtors Turnover Ratio

Highest at 8.09 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -32.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Anglikang Pharmaceutical Co. Ltd.

Operating Cash Flow

Lowest at CNY 194.68 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio

Highest at 1.27 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.92 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio